Research has shown that CBD may be useful in easing different types of chronic pain. Neuropathic pain falls into this category, but unlike other chronic pain conditions, neuropathy is particularly difficult to treat, according to the author of a paper on neuronal mechanisms of neuropathic pain.
As for the results, I was satisfied when it came to pain and irritation. I also noticed that my stomach was calmer than before taking this oil. However, there’s a reason why I’ve placed CBDistillery at the very bottom of this compilation. Unlike competitor brands, this one doesn’t use organic hemp plants.
CBD also has more than 65 molecular targets. It can interact with other receptors in the body, such as the 5-HT1A serotonin receptor. Serotonin is a neurotransmitter that controls feelings of well-being and emotional stability. It can also modulate nausea, anxiety, and pain.
Why Some People Are Choosing CBD Oil for Neuropathy
As for hemp oil, which is often added to CBD topicals, it’s an excellent source of essential fatty acids and amino acids. You can also look for topicals infused with primrose oil for enhanced anti-inflammatory effects.
Everybody will react to CBD differently because we’re not made the same. You need to ask yourself a few questions.
CBD pure is also one of the most transparent companies on the market. The guys at CBDPure explain every step of how their oils are made, and surprisingly for low-potency extracts, these products provide decent results when it comes to pain relief. The only reason CBDPure scores third place on this list is because of the higher prices. Some users may find these oils less affordable than other premium brands in the long run.
The nerves are important players for any kind of pain, as well as other types of sensations. According to Dr. Ryan Jacobs, a neuromuscular neurologist, pain messages are sent by the nerves. This often happens as a result of inflammation or injury that causes damage to body tissues such as skin, bones, or muscles. However, nerve pain refers to damage caused by an injury to the nerves on their own. He also added that in some cases, it can be damage to one significant nerve or a few minor ones that can contribute to a widespread nerve injury.
Among patients who used cannabis as a direct strategy to manage their lupus symptoms, 83% said they would recommend it to another person with lupus. Yet 96% of respondents reported that their doctors had not talked with them about using cannabis to treat lupus, which indicates that most people are seeking out medical marijuana on their own.
CBD may relieve neuropathic pain by activating the brain’s serotonin receptors. Photo by: Gina Coleman/Weedmaps
Many medical experts are tentatively on board with cannabis as a viable treatment option for chronic pain and many see potential in CBD. Photo by: Gina Coleman/Weedmaps
“Medical marijuana, in my opinion, is an excellent choice for patients with chronic disease, including chronic pain,” Mechtler said in a March 2019 interview with the Chicago Tribune.
“CBD may offer an option for treating different types of chronic pain,” he wrote. “A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis.
Reuters reported on Feb. 6, 2019, that pain is by far the top reason why U.S. patients seek out medical cannabis. Word of mouth is a primary factor in people seeking cannabis medicine to soothe their pain, and there are ample studies to support these anecdotal reports. It is unclear whether CBD in the absence of other cannabinoids and terpenes can provide a remedy to neuropathy.
Neuropathic pain is a component of osteoarthritis. In an animal model of arthritis, researchers showed that when taken prophylactically, CBD can prevent the pain and nerve damage produced by arthritis. These results were published in 2017, also in the academic journal Pain.
Conclusion: Our findings demonstrate that the transdermal application of CBD oil can achieve significant improvement in pain and other disturbing sensations in patients with peripheral neuropathy. The treatment product was well tolerated and may provide a more effective alternative compared to other current therapies in the treatment of peripheral neuropathy.
Background: Peripheral neuropathy can significantly impact the quality of life for those who are affected, as therapies from the current treatment algorithm often fail to deliver adequate symptom relief. There has, however, been an increasing body of evidence for the use of cannabinoids in the treatment of chronic, noncancer pain. The efficacy of a topically delivered cannabidiol (CBD) oil in the management of neuropathic pain was examined in this four-week, randomized and placebocontrolled trial.
Results: The study population included 62.1% males and 37.9% females with a mean age of 68 years. There was a statistically significant reduction in intense pain, sharp pain, cold and itchy sensations in the CBD group when compared to the placebo group. No adverse events were reported in this study.
Methods: In total, 29 patients with symptomatic peripheral neuropathy were recruited and enrolled. 15 patients were randomized to the CBD group with the treatment product containing 250 mg CBD/3 fl. oz, and 14 patients were randomized to the placebo group. After four weeks, the placebo group was allowed to crossover into the treatment group. The Neuropathic Pain Scale (NPS) was administered biweekly to assess the mean change from baseline to the end of the treatment period.
Keywords: CBD; cannabis sativa; diabetic neuropathy; hemp; nerve pain; review..